Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Frassoni

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patientsG Martinelli, I Iacobucci, G Rosti, et al.
Experimental Hematology|March 8, 2000
Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesisM Podestà, G Piaggio, M Sessarego, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Tumori|October 31, 1981
High dose BCNU followed by autologous bone marrow infusion in glioblastoma multiformeA M Carella, D Giordano, G Santini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplantsA Bacigalupo, T Lamparelli, F Gualandi, et al.
Lancet (London, England)|May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow TransplantationF Frassoni, M Labopin, R Powles, et al.
Bone Marrow Transplantation|April 20, 2004
Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cellsB Sirohi, R Powles, S Kulkarni, et al.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Bone Marrow Transplantation|April 15, 2003
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusionsA M Raiola, M T Van Lint, M Valbonesi, et al.
Bone Marrow Transplantation|August 16, 2002
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeA Urbano-Ispizua, N Schmitz, T de Witte, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patientsG Martinelli, I Iacobucci, G Rosti, et al.
Experimental Hematology|March 8, 2000
Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesisM Podestà, G Piaggio, M Sessarego, et al.
Lancet (London, England)|November 3, 1998
Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Gratwohl, J Hermans, J M Goldman, et al.
Tumori|October 31, 1981
High dose BCNU followed by autologous bone marrow infusion in glioblastoma multiformeA M Carella, D Giordano, G Santini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 14, 2003
Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplantsA Bacigalupo, T Lamparelli, F Gualandi, et al.
Lancet (London, England)|May 3, 2000
Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow TransplantationF Frassoni, M Labopin, R Powles, et al.
Bone Marrow Transplantation|April 20, 2004
Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cellsB Sirohi, R Powles, S Kulkarni, et al.
British Journal of Haematology|December 1, 1996
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)A Gratwohl, J Hermans, A van Biezen, et al.
Bone Marrow Transplantation|April 15, 2003
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusionsA M Raiola, M T Van Lint, M Valbonesi, et al.
Bone Marrow Transplantation|August 16, 2002
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeA Urbano-Ispizua, N Schmitz, T de Witte, et al.
Pageof 22